MYOS - MYOS RENS Technology Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

MYOS RENS Technology Inc.

45 Horsehill Road
Suite 106
Cedar Knolls, NJ 07927
United States

IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees12

Key Executives

NameTitlePayExercisedYear Born
Dr. Robert Joseph HaririChairman of Board & Chairman of the Scientific Advisory BoardN/AN/A1959
Mr. Joseph MannelloCEO & Director43.36kN/A1958
Mr. Ren RenGlobal ChairmanN/AN/A1962
Mr. Joseph DiPietroControllerN/AN/AN/A
Mr. Magshoud DarianiChief Technology OfficerN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


MYOS RENS Technology Inc. focuses on the discovery, development, and commercialization of nutritional and therapeutic products that enhance muscle health and performance. The company primarily focuses on developing products that enhance muscle health and function essential to the management of sarcopenia, cachexia, and degenerative muscle diseases, and as an adjunct to the treatment of obesity. Its products include Qurr line of products comprising flavored puddings, powders, and shakes; Yolked line of products for collegiate and professional athletes; and Myos Canine Muscle Formula line of products for pets. The company sells its products through direct-to-consumer e-commerce platform; and at the Vitamin Shoppe. MYOS RENS Technology Inc. has a research agreement with the University of California to study the effects Of Fortetropin on skeletal muscle protein synthetic rate in older men and women; Rutgers University for the discovery development and commercialization of products that improve muscle health and performance; Weill Cornell Medical College to study the efficacy of Fortetropin in preventing weight and muscle loss associated with cancer; and McMaster University to study impact of Fortetropin on muscle disuse atrophy in young men. The company was formerly known as MYOS Corporation and changed its name to MYOS RENS Technology Inc. in March 2016. MYOS RENS Technology Inc. was founded in 2007 and is based in Cedar Knolls, New Jersey.

Corporate Governance

MYOS RENS Technology Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.